The aim of this study was to learn more about the role of the HIV-related chemokine-chemokine receptor axes in human hematopoiesis. To address this issue we phenotyped 35 selected hematopoietic cell lines for the expression of CD4, CXCR4 and CCR5. We next evaluated the functionality of these chemokine receptors by calcium flux and chemotaxis assays, and by the ability of SDF-1, MIP-1␣, MIP-1␤ and RANTES to influence the growth of the cells expressing CXCR4 and/or CCR5. Lastly, we examined whether human hematopoietic cell lines may secrete some HIV-related chemokines, and whether endogenously secreted chemokines might interfere with the infectability of hematopoietic cells by X4 and R5 HIV strains. These results demonstrate that: (1) HIV-related receptors are widely expressed on human hematopoietic cell lines; (2) stimulation of CXCR4 by SDF-1 induces calcium flux and chemotaxis in several hematopoietic cell lines more efficiently than stimulation of CCR5 by receptor-specific ␤-chemokines; (3) chemokines do not regulate proliferation of the hematopoietic cells; and finally (4) infectability of the hematopoietic cells by HIV-1 may be auto-modulated by endogenously secreted chemokines. These data shed more light on the role of HIV-related chemokine-chemokine receptors axes in human hematopoiesis and interaction of hematopoietic cells with HIV. Leukemia (2000) 14, 1821-1832.
Introduction
HIV viruses enter human cells after binding to CD4 antigen in addition to one of the chemokine receptors. R5 viruses (macrophagotropic) utilize the CCR5 co-receptor and X4 viruses (lymphotropic) the CXCR4 receptor, respectively. Some viral strains may also enter cells in a CD4-independent manner or utilize other chemokine receptors that function as HIV-1 co-receptors for possible entry. [1] [2] [3] [4] [5] [6] [7] Chemokine receptors possess a seven span transmembrane protein molecular structure and are coupled to G signaling proteins. [8] [9] [10] [11] The major R5 HIV-1 co-receptor (CCR5) binds the ␤-chemokines MIP-1␣, MIP-1␤ and RANTES, whereas the major X4 HIV coreceptor (CXCR4) binds ␣-chemokine SDF-1. [3] [4] [5] The role of the chemokine-chemokine receptor axes in regulating the biology of human hematopoietic cells is still not fully understood. As an example, MIP-1␣ has been reported to inhibit, [12] [13] [14] [15] stimulate, 16, 17 or have no effect on the proliferation of normal human hematopoietic cells. [18] [19] [20] The other two HIV-related CCR5 binding chemokines (MIP-1␤ and RANTES) did not affect the proliferation of cells.
12,13 SDF-1 -ligand for the CXCR4 receptor has been reported to have no effect on the proliferation of human hematopoietic cells. [21] [22] [23] [24] [25] In a recently published study, however, SDF-1 has been reported to inhibit growth of myeloid progenitor cell line. Chemokines may also exert different effects on hematopoiesis, for example, they may regulate the adhesive properties of cells, 6 and/or influence trafficking and homing of cells in various lympho-hematopoietic organs. 27, 28 The aim of this study was to evaluate the expression of the chemokine receptors on human cells derived from the different hematopoietic lineages (erythroid, megakaryocytic, myeloid, T and B lymphoid lines), and to learn more about the biological role of chemokines in regulating the biology of hematopoietic cells.
We observed that chemokine receptors are broadly expressed on human hematopoietic cell lines, however, their expression does not correlate uniformly with functional capacity. Of note, we found that while SDF-1 activates calcium flux and chemotaxis in several CXCR4
+ human hematopoietic cell lines, MIP-1␣, MIP-1␤ or RANTES did not stimulate calcium flux and chemotaxis of CCR5 + cell lines employed in this study. Furthermore, chemokines did not influence the proliferation of CXCR4
+ or CCR5 + cell lines, even when the corresponding receptors were found to be functional by calcium flux or chemotaxis assay. Our studies also showed that human T and B hematopoietic cell lines may secrete HIV-related chemokines. We observed that these endogenously secreted chemokines may influence the infectability of hematopoietic cells by both R5 and X4 HIV strains. In toto these data are helpful in understanding and interpreting the role of HIV-related chemokine-chemokine receptor axes in human hematopoiesis, and may provide important clues in understanding interaction of hematopoietic cells with HIV.
Material and methods

Cell lines
All cell lines employed in these studies were maintained in RPMI medium (Gibco BRL, Long Island, NY, USA) supplemented with 10% bovine calf serum (BCS) (Hyclone, Logan, UT, USA). K-562, HL-60, HEL, Jurkat and UT-7 hematopoietic cell lines were purchased from ATCC (Rockville, MD,USA). Other hematopoietic cell lines were maintained in the laboratory of one of us (MAW) in agreement with the guidelines for the characterization and publication of human maligant hematopoietic cell lines. 29 
FACS analysis of chemokine receptor expression
The expression of CCR5 and CXCR4 on different human hematopoietic cell lines was evaluated by FACS as described. 7, 25 The MoAbs employed for the chemokine receptor expressions were a gift from R&D Systems (Minneapolis, MN, USA). Briefly, the cells were stained in PBS (Ca and Mg free) supplemented with 5% BCS (Hyclone). Primary MoAbs were detected with secondary PE-conjugated goat anti-mouse MoAbs (Sigma, St Louis, MO, USA) (1:100). After the final wash, cells were fixed in 1% paraformaldehyde prior to FACS analysis. Analysis was performed using the FACscan (Becton Dickinson, San Jose, CA, USA).
Chemotaxis studies
All experiments were performed in triplicate. Briefly, after isolation the cells were resuspended in serum-free medium (10 6 /ml) and equilibrated for 10 min at 37°C. Pre-warmed serum-free medium (600 l) containing the appropriate ligand (300 ng/ml) was added to the lower chamber of a Costar Transwell 24-well plate, 6.5 mm diameter, 5-8 M pore filter (Costar Corning, Cambridge, MA, USA). Subsequently, 100 l aliquots of the cell suspension were distributed to the upper chambers and cultures were incubated at 37°C, 95% humidity, 5% CO 2 for 3 h. After 3 h of incubation the cells from the lower chambers were collected and the cell number was scored by FACscan (Becton Dickinson). Briefly, the cells were gated according to their forward scatter (FSC) and sideward scatter (SSC) parameters and counted during a 20 s acquisition at high flow rate. Data are demonstrated as a percentage of the input number of the cells.
Calcium flux studies by spectophotofluorimeter
Calcium flux studies on cells from different human hematopoietic cell lines were performed using the spectophotofluorimeter as described. 7, 25 Briefly, cells were resuspended in prewarmed loading buffer (1 × Hank's buffered salt solution containing 1 mM CaCl 2 , 1 mM MgCl 2 and 1% low IgG FBS) to a final concentration of 10 7 /ml. Subsequently, Fura-2/AM (Molecular Probes, Eugene, OR, USA) was added to a final concentration of 1-2 M, and cells were incubated for 30 min at 30°C. After incubation cells were washed once, resuspended in loading buffer without FBS, stimulated with appropriate ligand (500 ng/ml) and analyzed within 1 h.
Proliferation assays
Cells were resuspended in Iscove's medium (Gibco BRL, Grand Island, NY, USA) supplemented with 10% of the artificial serum as previously described. 30, 31 Cultures were performed in 96-well plates. The cells from the various hematopoietic cells lines (2 × 10 3 cells/ml) were resuspended in 1 ml of the culture medium without or in the presence of 5 ng (low dose) or 50 ng/ml (high dose) of the following chemokines: SDF-1␣, SDF-1␤, MIP-1␣, MIP-1␤, RANTES (R&D, Minneapolis, MN,USA). The cells in the wells were counted at days 7 and 14. Four wells were counted per point.
ELISA assays
Secretion of MIP-1␣, MIP-1␤ and RANTES by hematopoietic cells was detected by Quantikine human MIP-1␣, MIP-1␤ and RANTES immunoassy (R&D) according to the manufacturer's protocol. Cells were cultured for 24 h in serum-free medium and supernatants collected and subjected to the quantitative sandwich enzyme immunoassay. The sensitivity of the ELISA assays for MIP-1␣, MIP-1␤ and RANTES was Ͼ31 pg/ml, у31 pg/ml and Ͼ15 pg/ml, respectively.
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Isolation of mRNA from cell lines
Cells were lysed in 200 l of RNAzol (Biotecx Labs, Houston, TX, USA) +22 l of chloroform as described 7, 25 and the aqueous phase was collected and mixed with 1 volume of isopropanol (Sigma). RNA was precipitated overnight at −20°C. The RNA pellet was washed in 75% ethanol and resuspended in three times-autoclaved H 2 O.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Briefly, mRNA (0.5 g) was reverse-transcribed with 500 U of Moloney murine leukemia virus reverse transcriptase (MoMLV-RT) and 50 pmol of an ODN primer complementary to the 3Ј of SDF-1 (5Ј-CAC ATG TTG AAC CTC TTG TTT AAA AGC-3Ј). The resulting cDNA fragments were amplified using 5 U of Thermus aquaticus (Taq) polymerase and primers specific for the 5Ј end of SDF-1 (5Ј-AAC GCC AAG GTC GTG GTC GTG CTG-3Ј). ␤-Actin mRNAs were amplified simultaneously using specific primers as reported previously. 7, 25 Amplified products (10 l) were electrophoresed on a 2% agarose gel and transferred to a nylon filter and further documented photographically. Specificity of the amplified products were further confirmed by Southern blotting (data not shown).
Infection of PB-1 cells with HIV
A T lymphocytic cell line PB-1 was maintained in RPMI (Gibco BRL) supplemented with 10% BCS (Hyclone). 30, 31 Cells were infected at day 0 by BAL (R5 HIV) or HXB2 (X4 HIV). HIV strains (a gift of Dr F Gonzales-Scarano, University of Pennsylvania, Philadelphia, PA) were employed at a multiplicity of infection (MOI) of 0.02. Briefly, 10 5 PB-1 cells were resuspended in 200 l of medium containing 2 ng HIV per infection, and subsequently 300 l of conditioned medium harvested from serum-free cultures of PB-1, HUT102B, 15A and K-562 cells were added to the cells. As controls we employed medium alone and conditioned media that were boiled before addition to the cultures. The cells were subsequently incubated for 24 h in 37°C, 5% CO 2 . After incubation, the cells were washed out and resuspended in DMEM + 10% BCS and placed into the tissue culture incubator. At days 1, 5 and 10 of the culture medium aliquots for p24 ELISA assays were aspirated.
Detection of p24 protein by ELISA
Infection of the cells was measured by employing sensitive p24 ELISA (NEN, Boston, MA, USA). The p24 protein was detected in supernatants collected from HIV-infected PB-1 cells according to the manufacturer's protocol.
Statistical analysis
Means and standard deviations were calculated on a MacIntosh computer using Instat 1.14 (GraphPad, San Diego, CA, USA) software. Data were analyzed using the Student's t-test for unpaired samples. Statistical significance was defined as P Ͻ 0.05. 
Results
CD4 and major HIV chemokine co-receptors are expressed on human hematopoietic cell lines
We phenotyped 35 different human hematopoietic cell lines, including a series of myeloid, B and T cell lymphocytic cells, for expression of CD4 and the major R5 HIV and X4 HIV-1 strain-related chemokine co-receptors CCR5 and CXCR4, respectively. The data of representative FACS studies are shown in Figure 1 , and summarized in Tables 1-4 . We demonstrated that HIV-related chemokine co-receptors are widely expressed on human hematopoietic cells. Interestingly, we found that the CD4 antigen was expressed on several human myeloid cells (TF-1, HL-60, HEL, UT-7 and DAMI) ( Table 1 ) in addition to T lymphocytic cell lines (Table  2 ). Some T cell lines, however, did not express the surface CD4 molecule (MOLT13, SUDHL-1, JB6 and 2A). As predicted, all B lymphocytic cell lines were negative for CD4 expression (Table 3) . Of note, one Hodgkin lymphoma cell line, L540, strongly expressed the CD4 molecule on the surface.
Both major HIV-related chemokine co-receptors CXCR4 and CCR5 were expressed on myeloid and lymphoid cells. The CCR5 co-receptor was expressed on five out of seven myeloid cell lines (Table 1) , whereas CXCR4 was present on HL-60 cells only. Interestingly, while CXCR4 was highly expressed on more immature B lymphocytic cell lines (proand pre-B), CCR5 was expressed on more differentiated B cells (Table 3 ). In contrast, however, no similar correlation could be made for CXCR4 and CCR5 expression and developmental status of T cells (Table 2) .
Calcium flux in cells expressing CXCR4 and CCR5 co-receptors
We next examined whether cell lines that expressed CXCR4 (HL-60, NALM6, Jurkat, ATL2, L428, PB-1, 2A, BL-1, 697, Sultan, 15A, Molt13 and Sez4) or CCR5 (K-562, HEL, DAMI, DAUDI, JB-6, BL-1, 697, SULTAN, Sez4, PB-1, 2A and Hs445) co-receptors on the surface would respond to chemokine binding in the calcium flux assay. Accordingly, target cells were loaded with Fura-2/AM and then stimulated with appropriate ligands -SDF-1 (Table 5) or MIP-1␤ (Table 6 ), respectively. We found that from the 13 cell lines tested -HL-60, NALM6, Jurkat, ATL2, PB1, 2A and 697 cells showed calcium flux after stimulation by SDF-1 (Table  6 ). An example of calcium flux in PB-1 and Jurkat cells after stimulation with SDF-1 is shown in Figure 2 . Interestingly, we 
observed that L428 and 15A cells that highly expressed CXCR4 on the surface did not show calcium flux after stimulation with SDF-1. Of note, all cell lines that displayed calcium flux after stimulation by SDF-1 also displayed chemotaxis to this chemokine (Table 6 ). In all, ෂ40% of the CXCR4 + cell lines did not respond to SDF-1 in the chemotaxis assay (L428, BL-1, 15A, MOLT13 and Sez4).
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To our surprise, none of the 12 CCR5 + cell lines employed in this study showed calcium flux after stimulation by MIP-1␤ (Table 6) . Similarly, none of the CCR5 + cell lines showed chemotaxis to MIP-1␤ or RANTES.
Chemotactic responses of selected hematopoietic cell lines (PB-1, ATL-2, 2A and Jurkat cells) to ␣-and ␤-chemokines are presented in Figure 3 . All cells tested were CXCR4 + (Table 3 ) and showed chemotaxis to SDF-1 (Table 5) . SDF-1, in particular, was a very strong chemoatractant for Jurkat and PB-1 cells (Figure 3) . Both 2A and PB-1 cells, which also express CCR5, failed to show chemotaxis to MIP-1␤ (Figure 3 , Table  6 ).
Effects of MIP-1␣, RANTES, MIP-1␤ and SDF-1␣ on the proliferation of CCR5
+ and CXCR4 + cell lines (Tables 1-4) we were always able to detect its expression at mRNA level by RT-PCR (data not shown). Subsequently, these 10 selected CCR5
+ and/or CXCR4 + cell lines (HEL, DAUDI, KG-1a, L-428, ATL-2, HL-60, PB-1, 2A, K-562 and Jurkat) were exposed to MIP-1␣, MIP-1␤, RANTES or SDF-1 (Figure 4 ). This represented four myeloid (HEL, KG-1a, HL-60 and K-562) and six lymphoid (DAUDI, L-428, ATL-2, PB-1, 2A and Jurkat) cell lines. To avoid any influence of other, unidentified serumderived factors, all experiments were performed under serumfree conditions. To our surprise, none of the chemokines tested in this study influenced the proliferation of hematopoietic cell lines (Figure 4 ).
Secretion of chemokines by human hematopoietic cell lines
Chemokines have recently been shown, by us and others, to be secreted by normal hematopoietic cells, and are thought to play an important role in the cross-talk between cells. 6 We hypothesized that hematopoietic cell lines can also secrete HIV-related chemokines. We therefore collected media conditioned by selected cell lines and assayed for the presence of the CCR5-related ␤-chemokines (MIP-1␣, MIP-1␤ and RANTES) using the sensitive ELISA assay. Since an ELISA assay is not commercially available for SDF-1, expression of SDF-1 was evaluated at the mRNA level by RT-PCR (Table 7) .
We found that several hematopoietic cells lines, especially of B and T cell origin, secreted CCR5-related chemokines. MIP-1␣ was secreted by HS445, HUT102B, 15A, RS11846, PB-1, HsSultan and BC-1, whereas MIP-1␤ was produced by HS445 and HUT102B, and RANTES was secreted by 15A, HS445, RS11846 and HUT102B cells. In contrast, only three out of 19 cell lines evaluated in this study expressed mRNA for SDF-1 (Jurkat, HUT-102B and PB-1). The expression of SDF-1 by HUT-102B cells was subsequently confirmed by Western blot (data not shown). 
Endogenously secreted chemokines modulate the infectibility of cells by HIV strains
In view of the above observations we hypothesized that endogenously secreted chemokines might somehow modulate infection by R5 or X4 HIV. To test this hypothesis, we infected T lymphocytic cells (PB-1) (previously found to be permissive to infection by both R5 and X4 HIV strains or HUT102B cells (positive by ELISA for MIP-1␣, MIP-1␤ and RANTES and positive by RT-PCR for SDF-1 mRNA). As a negative control the same conditioned media that were first heat inactivated were used.
Infectivity and inhibition of infectivity were examined by both morphologic criteria ( Figure 5 ) and by p24 antigen production ( Figure 6 ). Conditioned media collected from 15A and HUT102B cells, which contain CCR5 binding chemokines, significantly decreased the infection of PB-1 cells by the R5 HIV strain ( Figure 5 , upper panels c and e). Infection of these target cells, however, was not affected by conditioned medium from the ␤-chemokine-negative HEL cells ( The results of p24 antigen production in these cultures is shown in Figure 6 . As above, PB-1 cells that were incubated with R5 HIV (BAL) (Figure 6 , left panels) in the presence of conditioned media from 15A (Figure 6b ) or HUT102B ( Figure  6c ) produced less p24 than cells incubated with heat-inactivated conditioned media from 15A and HUT102B lines (P Ͻ 0.0001). Similar analysis conducted using X4 HIV (HXB2) (Figure 6 , right panels) showed an inhibiting p24 production in cultures containing HUT102B (Figure 6c ) conditioned media (P Ͻ 0.0001), but not that from HEL (Figure 6a ) or 15A (Figure 6b ).
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Discussion
To learn more about the role of HIV-related chemokine receptors in human hematopoiesis we: (1) phenotyped various human hematopoietic cell lines for expression of CXCR4 and CCR5; (2) studied biological responses of these receptors in calcium flux and chemotaxis assays; (3) investigated the effect of chemokines on hematopoietic cell proliferation; (4) examined whether chemokines are endogenously secreted by hematopoietic cell lines; and finally (5) determined whether endogenously secreted chemokines interfere with HIV infection of hematopoietic cell lines.
We observed that several human hematopoietic cell lines express CD4 and HIV coreceptors CCR5 and CXCR4. We next identified several cell lines that should be susceptible to infection by either X4 or R5 strains. Accordingly, C91PL, PB-1, Sez4 and L540 cells, which are CD4 Several human hematopoietic cell lines were previously shown to support HIV infection (HEL, Jurkat, DAMI and MOLT4), and have been employed as experimental models in AIDS research. [33] [34] [35] [36] [37] Here, we identified additional cell lines (PB-1, Sez-4, HUT102B, ATL-2, C91PL, L540, C10MJ2 and Karpas 299) which should also be useful tools for studying various aspects of HIV biology. The possibility that human hematopoietic cell lines could become infected by HIV should always be kept in mind, especially in those laboratories that have broad access to human blood products.
Figure 4
Selected human hematopoietic cells lines were maintained in artificial serum supplemented Iscove's DMEM medium and then stimulated with various chemokines (SDF-1␣, MIP-1␣, MIP-1␤ or RANTES). Proliferation was determined by direct cell counts at days 4, 7 and 14. Results represent the mean of duplicate experiments.
Human hematopoietic cell lines maintained in these laboratories could acquire a virus from cells from HIV-positive patients by cross-contamination and become a potential reservoir of HIV.
To our surprise, we noticed that the CD4 antigen, which is a typical marker of T lymphocyte subsets is expressed on the surface of several human myeloid cells lines (TF-1, HEL, HL-60, DAMI and UT-7). It has been reported that the CD4 antigen is present on normal human megakaryocytes, 25 monocytes, 38 and differentiating erythroblasts. 7 The biological significance of the CD4 antigen expression on both normal and malignant human myeloid cells requires further studies.
Since the effects of chemokines on cell proliferation remain controversial, we incubated 10 different CXCR4
+ and/or CCR5 + human hematopoietic lines with SDF-1, MIP-1␣, MIP-1␤ or RANTES. We did not detect any effect of these chemokines on proliferation either in serum-free or serum-supplemented cultures, even if particular receptors were expressed and functional as assessed by calcium flux and/or chemotaxis assays. These data suggest that chemokines do not directly influence cell proliferation.
Our data are in agreement with a recent report from Drexler et al 8 who did not find any effect of RANTES, MIP-1␣ and MCP-1 on proliferation of 19 different myeloid leukemic cell lines, but contradict a report from Sanchez et al, 26 who found that SDF-1 strongly inhibits proliferation of murine hematopoietic cells. This latter observation, however, is somehow unexpected because SDF-1, which is a strong chemoattractant for human hematopietic progenitors, does not inhibit the proliferation of human cells. 21, 23, 24, 39 Generally, the data on the effect of chemokines on proliferation of both normal 6, 13, 14, 16, 19, 22, 39 and malignant 6, 18, 26 hematopoietic cells are often contradictory and may depend on such things as: (1) the source of chemokines; (2) modification of chemokine receptor function and their expression by factors released by hematopoietic accessory cells; and (3) formation of inactive dimers by chemokines in solution. 6, 7, 14, 40 Proliferation assays in our studies were performed in a culture supplemented with chemically defined artificial serum to eliminate the influence of confounding factors (usually present in different batches of animal or human sera) and the cells were stimulated by commercially available highly purified recombinant chemokines.
Furthermore, we determined here that the expression of a particular chemokine receptor does not necessarily correlate with biological function. We observed that while several human hematopoietic CXCR4
+ cell lines responded to SDF-1 The functional responses of malignant human hematopoietic cells to stimulation by ␣-and ␤-chemokines are similar to those previously reported by our laboratories using normal human hematopoietic cells. 39 Primary human hematopoietic cells (CD34 + cells or megakaryoblasts) displayed chemotaxis and calcium flux after stimulation with SDF-1 but not with MIP-1␣ or MIP-1␤. 39 The relative unresponsiveness of the CCR5 receptor on human hematopoietic cells could be potentially explained by the differences in sulfation of the CCR5 receptor, 41 cross-desensitization of chemokine receptors, 11 or by differences in the biological function of RGS proteins. 10 Moreover, hematopoietic cells might also become resistant to stimulation with exogenous chemokines if they endogenously secrete chemokines. [42] [43] [44] [45] [46] [47] It has also been shown that endogenously secreted chemoLeukemia kines might protect normal human immunocompetent cells (CD8 + and CD4 + T cells and NK cells) from HIV infection. [42] [43] [44] [45] [46] [47] In agreement with these observations, we recently reported that normal human hematopoietic cells (CD34 + cells and megakaryoblasts) also secrete HIV-related ␤-chemokines, and postulated that the latter may autoprotect hematopoietic cells from infection by R5 HIV strains. 48 However, the amount of chemokine secreted by these cells is generally small. Luster et al argued that since endogenously secreted ␤-chemokines are complexed with proteoglycans they may compete more effectively with HIV binding to CCR5 than uncomplexed recombinant chemokines. 43 In this study, we found that several human T and B cell lines may secrete CCR5-binding ␤-chemokines as well as the CXCR4 ligand SDF-1␣ and that chemokines endogenously secreted by established human hematopoietic cell lines, similarly to chemokines secreted by normal lympho-hematopoietic cells, [42] [43] [44] [45] [46] [47] might interfere with the infectability of the cells by R5 and X4 HIV strains. Of note, as a target for HIV infection we employed PB-1 cells, which are infectable by both R5 and X4 HIV. 32, 48 Interestingly, however, as we found that these
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Figure 6
p24 antigen production in HIV infected cultures. p24 HIV protein (pg/ml) was determined in conditioned media collected from PB-1 cells 10 days after infection with R5 HIV (BAL) or X4 HIV (HXB2) in the presence of fresh conditioned media (white bars) collected from HEL (a), 15A (b) or HUT102B (c) cells or heat inactivated conditioned media collected from the same cells (black bars). Results represent the mean of duplicate experiments. *P Ͻ 0.0001 as compared to fresh medium. cells also secrete some HIV-protective chemokines, we predicted that the relatively low secretion of RANTES and SDF-1 by these cells may explain why they remain permissive to infection by R5 and X4 HIV, respectively.
In conclusion, these data are important from the hematological point of view as we demonstrated that: (1) expression of chemokine receptors does not necessarily correlate with their functional responses in calcium flux and chemotaxis assays; (2) the CXCR4 receptor appears to be more biologically functional in human hematopoietic cells than the CCR5 receptor; and (3) chemokines do not influence proliferation of hematopoietic cell lines, even when the functionally relevant receptors are present on the cells. These data are also significant with respect to HIV research as: (1) we identified several human cell lines which may be employed as models for HIV infection studies; (2) we found that HIV-related receptors are expressed on many human hematopoietic cell lines (myeloid and lymphoid) and thus human hematopoietic cell lines may potentially serve as a reservoir of HIV; and (3) we demonstrate that the infectability of human hematopoietic cell lines may be automodulated by endogenously secreted chemokines. Finally, our data could be of special interest to all those researchers who are studying the role of chemokinechemokine receptor axes in cell biology.
